Cargando…
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease
OBJECTIVE: To investigate CSF biomarkers of neuroinflammation and neurodegeneration in Huntington disease (HD) gene-expansion carriers compared to controls and to investigate these biomarkers in association with clinical HD rating scales and disease burden score. METHODS: We collected CSF from 32 pr...
Autores principales: | Vinther-Jensen, Tua, Börnsen, Lars, Budtz-Jørgensen, Esben, Ammitzbøll, Cecilie, Larsen, Ida U., Hjermind, Lena E., Sellebjerg, Finn, Nielsen, Jørgen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042104/ https://www.ncbi.nlm.nih.gov/pubmed/27734023 http://dx.doi.org/10.1212/NXI.0000000000000287 |
Ejemplares similares
-
A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington’s disease
por: Vinther-Jensen, Tua, et al.
Publicado: (2014) -
Endophenotypical drift in Huntington’s disease: a 5-year follow-up study
por: Hellem, Marie N. N., et al.
Publicado: (2021) -
Hybrid 2-[(18)F] FDG PET/MRI in premanifest Huntington’s disease gene-expansion carriers: The significance of partial volume correction
por: Hellem, Marie N. N., et al.
Publicado: (2021) -
Social Cognition, Executive Functions and Self-Report of Psychological Distress in Huntington’s Disease
por: Larsen, Ida Unmack, et al.
Publicado: (2016) -
Progressive multiple sclerosis, cognitive function, and quality of life
por: Højsgaard Chow, Helene, et al.
Publicado: (2018)